Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services. — CFSMEATLAS
Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services.
Parslow, Roxanne M, Shaw, Alison, Haywood, Kirstie L et al. · BMC pediatrics · 2017 · DOI
Quick Summary
This study asked specialist doctors and nurses who treat children with ME/CFS what they believe are the most important things to measure when checking how well a child is doing. The experts identified four key areas: symptoms (like fatigue and pain), physical ability to do things, participation in school and social activities, and emotional wellbeing. The goal is to create a better way to measure treatment success that matches what children and families actually care about.
Why It Matters
This study bridges the gap between what clinicians observe and what matters most to children and families with ME/CFS, helping ensure future treatment assessments and clinical trials measure outcomes that are truly meaningful. By involving specialist expertise, it strengthens the case for patient-centered care in paediatric ME/CFS and supports development of better tools to track real-world improvement.
Observed Findings
Health professionals identified four key domains for assessing severity and treatment outcomes: symptoms, physical function, participation in school/activities/social life, and emotional wellbeing.
All 15 health professionals recognized ME/CFS impacts multiple aspects of children's health simultaneously.
Professionals emphasized that increases in physical function should be balanced with maintaining school engagement and broader participation as important treatment goals.
The study sample included diverse clinical disciplines with experience ranging from 2 months to 25 years in paediatric CFS/ME care.
Health professionals described complexity of the condition and importance of considering contextual factors when planning treatment.
Inferred Conclusions
Clinically important outcomes in paediatric ME/CFS are multidimensional rather than focused on single symptoms, requiring assessment across physical, functional, social, and psychological domains.
Maintaining or improving participation in valued activities (especially school) is as important to clinicians as physical symptom improvement.
A new patient-reported outcome measure should integrate both professional clinical expertise and direct patient/family priorities to ensure clinical utility and relevance.
Remaining Questions
Do children and families with ME/CFS prioritize the same outcome domains as health professionals, and are there important differences?
What This Study Does Not Prove
This study does not identify which treatments are effective for children with ME/CFS, nor does it test any specific interventions. It also does not establish how to measure these outcomes quantitatively or demonstrate that professionals' views match actual patient priorities in real clinical practice, though the authors note alignment with concurrent child-focused research.
How can these identified domains be reliably and validly measured in a new paediatric-specific outcome instrument?
Do these outcome priorities differ based on disease severity or stage of illness in children with ME/CFS?
How well do these clinically-identified outcomes predict meaningful long-term improvements in quality of life and functioning for children with ME/CFS?